65 related articles for article (PubMed ID: 22104637)
1. Delayed-onset obsessive-compulsive symptoms after brain infarctions treated with paroxetine.
Muneoka K; Shirayama Y; Kon K; Kawabe M; Kimura S
Clin Neuropharmacol; 2011; 34(6):260-1. PubMed ID: 22104637
[TBL] [Abstract][Full Text] [Related]
2. [Amnesic presentations of the compulsive obsessional confusions (about 3 patients appearing in a consultation of memory)].
Thomasantérion C; Cadet L; Dirson S; Laurent B
Encephale; 2002; 28(2):154-9. PubMed ID: 11972142
[TBL] [Abstract][Full Text] [Related]
3. Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine.
Matsui T; Saxena S; Kawabe J; Matsunaga H; Kohagura K; Higashiyama S; Kiriike N
Psychiatry Clin Neurosci; 2007 Apr; 61(2):186-9. PubMed ID: 17362437
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Kamijima K; Aoki M
Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
[TBL] [Abstract][Full Text] [Related]
5. Clozapine for blepharospasm, obsessive-compulsive symptoms, and psychotic symptoms in a patient of old brain infarction.
Sun CH; Lu CH; Huang TL
Clin Neuropharmacol; 2006; 29(6):368-70. PubMed ID: 17095902
[TBL] [Abstract][Full Text] [Related]
6. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
Hollander E; Dell'Osso B
Int Clin Psychopharmacol; 2006 May; 21(3):189-91. PubMed ID: 16528143
[TBL] [Abstract][Full Text] [Related]
7. Late-onset obsessive-compulsive disorder: the role of stressful life events.
Velayudhan L; Katz AW
Int Psychogeriatr; 2006 Jun; 18(2):341-4. PubMed ID: 16420720
[TBL] [Abstract][Full Text] [Related]
8. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
Ravindran AV; Lapierre YD; Anisman H
Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
[TBL] [Abstract][Full Text] [Related]
9. Association of temporal lobe epilepsy and obsessive-compulsive disorder in a patient successfully treated with right temporal lobectomy.
Barbieri V; Lo Russo G; Francione S; Scarone S; Gambini O
Epilepsy Behav; 2005 Jun; 6(4):617-9. PubMed ID: 15907757
[TBL] [Abstract][Full Text] [Related]
10. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
[TBL] [Abstract][Full Text] [Related]
11. Obsessive-compulsive symptoms in primary focal dystonia: a controlled study.
Barahona-Corrêa B; Bugalho P; Guimarães J; Xavier M
Mov Disord; 2011 Oct; 26(12):2274-8. PubMed ID: 21830232
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive disorder following cavernous sinus thrombosis.
Garyfallos G; Papazisis G; Katsigiannopoulos K; Bozikas VP; Adamopoulou A
J Neuropsychiatry Clin Neurosci; 2009; 21(4):473-4. PubMed ID: 19996263
[No Abstract] [Full Text] [Related]
13. Diagnosis and treatment of an obsessive-compulsive disorder following traumatic brain injury: a single case and review of the literature.
Hofer H; Frigerio S; Frischknecht E; Gassmann D; Gutbrod K; Müri RM
Neurocase; 2013 Aug; 19(4):390-400. PubMed ID: 22784309
[TBL] [Abstract][Full Text] [Related]
14. New-onset obsessive-compulsive disorder following neurosurgery for medication-refractory seizure disorder.
Roth RM; Jobst BC; Thadani VM; Gilbert KL; Roberts DW
Epilepsy Behav; 2009 Apr; 14(4):677-80. PubMed ID: 19435591
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy complicated by obsessive-compulsive disorder.
Chelmow D; Halfin VP
J Matern Fetal Med; 1997; 6(1):31-4. PubMed ID: 9029382
[TBL] [Abstract][Full Text] [Related]
16. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
Sevincok L; Topuz A
J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
[TBL] [Abstract][Full Text] [Related]
17. Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings.
Szeszko PR; MacMillan S; McMeniman M; Lorch E; Madden R; Ivey J; Banerjee SP; Moore GJ; Rosenberg DR
Neuropsychopharmacology; 2004 Apr; 29(4):826-32. PubMed ID: 14970831
[TBL] [Abstract][Full Text] [Related]
18. [The Yale-Brown Scale: instrument for assessing the severity of obsessive-compulsive disorders].
Kiejna A; Grzesiak M; Małyszczak K
Psychiatr Pol; 1998; 32(1):69-76. PubMed ID: 9594585
[TBL] [Abstract][Full Text] [Related]
19. Obsessive-compulsive disorder associated with parietal white matter multiple sclerosis plaques.
Douzenis A; Michalopoulou PG; Voumvourakis C; Typaldou M; Michopoulos I; Lykouras L
World J Biol Psychiatry; 2009; 10(4 Pt 3):956-60. PubMed ID: 19995223
[TBL] [Abstract][Full Text] [Related]
20. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.
Szeszko PR; Ardekani BA; Ashtari M; Malhotra AK; Robinson DG; Bilder RM; Lim KO
Arch Gen Psychiatry; 2005 Jul; 62(7):782-90. PubMed ID: 15997020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
